BIOCQ Dividend: Biocept Inc Yield Insights

최신 재무제표(Form-10K)에 따르면, Biocept Inc의 총 자산은 $30이며, 순loss입니다.

Biocept Inc의 유동비율은 1.36이고, 순이익률은 -128, 주당 매출은 $43.85입니다.

Currently Biocept Inc data is not available.

no, 최신 재무제표에 따르면 Biocept Inc의 순loss은 $-32입니다.

yes, Biocept Inc의 부채는 22입니다.

Biocept Inc의 총 발행 주식은 0.57주입니다.

Income

Balance sheet

Cash flow

Annual

Quarterly

BIOCQ Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	1	25	61	27	5	3
Revenue Growth (YoY)	-98%	-59%	126%	440%	67%	-40%
Cost of Revenue	15	28	37	21	10	10
Gross Profit	-14	-2	23	6	-5	-6
Selling, General & Admin	14	23	20	16	12	12
Research & Development	4	6	4	5	4	4
Operating Expenses	18	29	25	21	17	17
Other Non Operating Income (Expenses)	2	0	0	-2	-1	0
Pretax Income	-30	-32	-2	-17	-25	-24
Income Tax Expense	0	0	0	0	0	0
Net Income	-30	-32	-2	-17	-25	-25
Net Income Growth	100%	1,500%	-88%	-32%	0%	19%
Shares Outstanding (Diluted)	1.04	0.57	0.49	0.39	0.07	0.01
Shares Change (YoY)	86%	16%	26%	457%	600%	--
EPS (Diluted)	-29.43	-56.29	-5.75	-45.66	-360.85	-2,521
EPS Growth	4%	878.99%	-87%	-87%	-86%	-60%
Free Cash Flow	-18	-14	2	-20	-23	-22
Free Cash Flow Per Share	-17.3	-24.56	4.08	-51.28	-328.57	-2,200
Gross Margin	-1,400%	-8%	37.7%	22.22%	-100%	-200%
Operating Margin	-3,300%	-124%	-3.27%	-55.55%	-459.99%	-800%
Profit Margin	-3,000%	-128%	-3.27%	-62.96%	-500%	-833.33%
Free Cash Flow Margin	-1,800%	-56%	3.27%	-74.07%	-459.99%	-733.33%
EBITDA	-32	-30	-1	-14	-23	-24
EBITDA Margin	-3,200%	-120%	-1.63%	-51.85%	-459.99%	-800%
D&A For EBITDA	1	1	1	1	0	0
EBIT	-33	-31	-2	-15	-23	-24
EBIT Margin	-3,300%	-124%	-3.27%	-55.55%	-459.99%	-800%
Effective Tax Rate	0%	0%	0%	0%	0%	0%